4.2.2.1Vertical

Detox & Medical Withdrawal Programs

Medically supervised detoxification and withdrawal management services.

Market snapshot

These figures describe Addiction & Substance Use Treatment (4.2.2), the segment that Detox & Medical Withdrawal Programs sits within. They are not figures for Detox & Medical Withdrawal Programs on its own.

FragmentationConsolidatingEstimate

No single discrete Census NAICS code covers addiction treatment, which spans outpatient centers (621420), residential (623220), and hospitals (622210), so the segment is not separately sized by the Census Bureau.

Business model & economics

Revenue model

Per-diem residential, outpatient, and MAT reimbursement

Key economics

Recurring revenue
Moderate–High

recurring MAT and outpatient care

EBITDA margin
12–22%
Capex intensity
Moderate

Characteristics

  • Demand driven by the opioid and addiction crisis.
  • MAT expanded evidence-based, recurring treatment.
  • Fraught history of scandals and quality concerns.

M&A deal context

Deal activityHigh

Who’s acquiring

  • PE-backed treatment platforms
  • MAT and outpatient consolidators
  • Behavioral-health operators

What’s driving deals

  • Consolidation of treatment providers.
  • Opioid-crisis and addiction demand.
  • Regulatory and reputational scrutiny.

Find Detox & Medical Withdrawal Programs acquisition targets

Search Acquisera’s index for companies classified under Detox & Medical Withdrawal Programs (4.2.2.1) and build a targeted deal pipeline.

Search companies